Novartis - History and Company profile (overview)

(2:36)

Why Novartis focuses on cancer drugs

(3:22)

Why Novartis is focusing on access to innovative medicines

(2:10)

Why Novartis focuses on cancer drugs

(3:22)

Novartis generated $40 billion in innovative medicine sales, says CEO

(3:29)

Why return to work at Novartis?

(1:28)

Reasons Why Novartis Stock Stands Out in the Booming Healthcare Sector

(4:21)

Why Novartis AG Stock is a Smart Investment in the Booming Healthcare Sector

(2:55)

Why Novartis is spinning off Alcon and sticking to Sandoz

(3:38)

Novartis as a focused innovative medicines company

(54)

The American Oligarchs - What is the Cost of American Democracy? | FD Finance

(1:24:59)

South Asian Trailblazers: Vas Narasimhan (CEO of Novartis) and Srishti Gupta (Leader in Health \u0026 Ed)

(1:14:3)

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company

(25:17)

Novartis CEO: Growth drivers performing well, but product exclusivity losses creating headwinds

(9:48)

Novartis CEO Vas Narasimhan on The David Rubenstein Show

(24:7)

Novartis CEO discusses how AI will impact drug development

(6:51)

Meet our people: Vas Narasimhan

(3:58)

Novartis is flipping the pyramid, explains Steven Baert

(25:51)

Novartis Campus Lecture - RNA Revolution: A Conversation with Nobel Prize winner Katalin Karikó

(1:13:57)

Novartis CEO Vas Narasimhan: Expect solid growth this year top and bottom line

(3:50)

Novartis – Who We Are

(52)

Novartis and Microsoft bring the power of AI to every employee

(1:47)

Novartis ‘focusing on high-end, innovative medicines,’ CEO says

(11:50)

Novartis Agrees to $6.8 Billion Medicines Co. Deal

(55)

Novartis: The making of a pharma giant

(2:55)

Novartis positioning is now best-suited for long-term gains and returns after spin-off, says CEO

(4:37)

Cramer’s Stop Trading: Novartis

(2:4)

Why Novartis focuses on cancer drugs

(3:22)

AI, vaccine distrust, \u0026 the future of healthcare: Novartis CEO

(24:1econd)